Ptc Therapeutics (PTCT) Other Non Operating Income (2012 - 2026)
Ptc Therapeutics (PTCT) posted quarterly Other Non Operating Income of -$3.0 million for Q2 2026, up 48.56% year-over-year from -$2.0 million in Q2 2025, and down 283.41% quarter-over-quarter from $1.6 million in Q1 2026.
Ptc Therapeutics (PTCT) Other Non Operating Income (2012 - 2026) Analysis & Trends
Ptc Therapeutics' Other Non Operating Income history runs 15 years deep, the most recent figure standing at -$3.0 million for Q2 2026.
- In Q2 2026, Other Non Operating Income rose 48.56% year-over-year to -$3.0 million; the TTM figure through Jun 2026 stood at $53.3 million (up 1153.06% YoY), while the FY2025 annual figure was $42.6 million, up 551.39% from the prior year.
- Other Non Operating Income for Q2 2026 stood at -$3.0 million, down from $1.6 million in the prior quarter.
- The five-year high for Other Non Operating Income was $48.2 million in Q4 2025, with the low at -$128.7 million in Q4 2023.
- The 5-year median for Other Non Operating Income is -$1.9 million (2024), against an average of -$7.7 million.
- The sharpest annual moves came in 2022 and 2025: Other Non Operating Income plunged 1183.82% in 2022, then surged 447.33% in 2025.
- Ptc Therapeutics' Other Non Operating Income stood at $35.1 million in 2022, then sank by 466.24% to -$128.7 million in 2023, then jumped by 106.88% to $8.8 million in 2024, then soared by 444.26% to $48.2 million in 2025, then slumped by 106.13% to -$3.0 million in 2026.
- Business Quant data shows PTCT's Other Non Operating Income at -$3.0 million in Q2 2026, $1.6 million in Q1 2026, and $48.2 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Ptc Therapeutics | 5.97 Bn | 3.75 Bn | 340.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.95 Mn |
| Mar 31, 2026 | 1.61 Mn |
| Dec 31, 2025 | -12.55 Mn |
| Sep 30, 2025 | 6.50 Mn |
| Jun 30, 2025 | -5.74 Mn |
| Mar 31, 2025 | -6.31 Mn |
| Dec 31, 2024 | -4.09 Mn |
| Sep 30, 2024 | -1.87 Mn |
| Jun 30, 2024 | -2.03 Mn |
| Mar 31, 2024 | 1.59 Mn |
| Dec 31, 2023 | -1.69 Mn |
| Sep 30, 2023 | -20.27 Mn |
| Jun 30, 2023 | 1.48 Mn |
| Mar 31, 2023 | 9.96 Mn |
| Dec 31, 2022 | 35.15 Mn |
| Sep 30, 2022 | -38.14 Mn |
| Jun 30, 2022 | -34.36 Mn |
| Mar 31, 2022 | -11.86 Mn |
| Dec 31, 2021 | -31.38 Mn |
| Sep 30, 2021 | -18.78 Mn |